Matthew W. Foehr
DirectoratViking Therapeutics· In proxies 2023–2025
Matthew W. Foehr sits on 1 public board.
Experience
- Viking TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +213%
- Ritter Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?